EUVIMEDEUVIMED entdecken
VergleichsstudieOpen Access · CC BY 4.0

Long-term outcomes of accelerated partial breast irradiation with multicatheter interstitial brachytherapy versus whole breast irradiation: an 11-Year clinical practice follow-up study

Sara Garduño-Sánchez, María Isabel Villanego-Beltrán, Juan Gómez-Salgado, Javier Jaén-Olasolo

Clinical and Translational Oncology · 2025

DOI: 10.1007/s12094-025-04060-3 ↗

Kurz gefasst

Vergleichsstudie in der Zeitschrift Clinical and Translational Oncology, 2025. Verfasst von Sara Garduño-Sánchez und 3 weiteren Autor:innen. Beteiligte Einrichtung: Department of Radiation Oncology, Juan Ramón Jimenez University Hospital, Andalusian Health Service, Ronda Norte S/N, 21005, Huelva, Spain. Hauptthemen laut MEDLINE: Brachytherapy, Breast Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 27 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Universidad de Huelva.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Purpose

To compare the long-term outcomes of accelerated partial breast irradiation (APBI) using multicatheter interstitial brachytherapy versus whole breast irradiation (WBI), in terms of late toxicity, cosmetic results, quality of life, and survival, in a real-world clinical setting.

Methods

Updated analysis of two prospectively collected cohorts comprising 76 patients with stage I–II breast cancer treated with breast-conserving surgery followed by adjuvant radiotherapy. Patients who underwent APBI met the GEC-ESTRO eligibility criteria. We assessed follow-up and additional analyses of late toxicity, quality of life (assessed using the validated QLQ-BR23 and S-BIS questionnaires), cosmetic outcomes (via Visual Analog Scale), overall survival (OS), and disease-free survival (DFS), providing a more comprehensive evaluation of long-term outcomes.

Results

At a median follow-up of 11 years, patient-reported quality of life remained significantly better in the APBI group, particularly in both physical and psychological domains, consistent with previous findings. No significant differences were observed in late clinical toxicity or cosmetic outcomes between groups. However, late mammographic findings showed a higher incidence of architectural distortion and tissue retraction in the APBI group, confirming earlier observations. The estimated 5- and 10-year OS rates were 94.7 and 81.1%, respectively. Corresponding DFS rates were 92.1% and 79.7%, with no statistically significant differences between treatment groups.

Conclusion

With extended follow-up, our results reinforce that APBI using multicatheter interstitial brachytherapy is a safe and effective alternative to WBI in selected patients, providing long-term tumor control and survival comparable to WBI, while offering improved quality of life.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

BrachytherapyBreast NeoplasmsHumansFemaleFollow-Up StudiesQuality of LifeMiddle AgedAgedMastectomy, SegmentalProspective StudiesAdultRadiotherapy, AdjuvantTreatment OutcomeDisease-Free SurvivalSurvival RateAged, 80 and over

Stichwörter der Autor:innen

Accelerated partial breast irradiationBreast cancerCancer survivalClinical OncologyCosmetic resultsLate ToxicityMulticatheter interstitial brachytherapyQuality of Life

Autor:innen und Institutionen

  • Department of Radiation Oncology, Juan Ramón Jimenez University Hospital, Andalusian Health Service, Ronda Norte S/N, 21005, Huelva, Spain.
  • Department of Radiation Oncology, Puerta del Mar University Hospital, Andalusian Health Service, Ana de Viya 21 Avenue, 11009, Cadiz, Spain.
  • Department of Sociology, Social Work and Public Health, Faculty of Labour Sciences, University of Huelva, Avenida Tres de Marzo, S/N, 21007, Huelva, Spain. salgado@uhu.es.
  • Safety and Health Postgraduate Programme, Universidad Espíritu Santo, Av Samborondón 5, 092301, Guayaquil, Ecuador. salgado@uhu.es.
  • Biomedical Research and Innovation Institute of Cádiz (INiBICA) Research Unit, Puerta del Mar University Hospital, Andalusian Health Service, Ana de Viya 21 Avenue, 11009, Cadiz, Spain.

Förderung

  • Universidad de Huelva

Zitieren

APA

Garduño-Sánchez, S., Villanego-Beltrán, M. I., Gómez-Salgado, J., & Jaén-Olasolo, J. (2025). Long-term outcomes of accelerated partial breast irradiation with multicatheter interstitial brachytherapy versus whole breast irradiation: an 11-Year clinical practice follow-up study. Clinical and Translational Oncology. https://doi.org/10.1007/s12094-025-04060-3

Vancouver

Garduño-Sánchez S, Villanego-Beltrán MI, Gómez-Salgado J, Jaén-Olasolo J. Long-term outcomes of accelerated partial breast irradiation with multicatheter interstitial brachytherapy versus whole breast irradiation: an 11-Year clinical practice follow-up study. Clinical and Translational Oncology. 2025. doi:10.1007/s12094-025-04060-3

BibTeX
@article{GarduoSnchez2025,
  author = {Garduño-Sánchez, Sara and Villanego-Beltrán, María Isabel and Gómez-Salgado, Juan and Jaén-Olasolo, Javier},
  title = {Long-term outcomes of accelerated partial breast irradiation with multicatheter interstitial brachytherapy versus whole breast irradiation: an 11-Year clinical practice follow-up study},
  journal = {Clinical and Translational Oncology},
  year = {2025},
  doi = {10.1007/s12094-025-04060-3}
}
Kostenlos starten →